NCT05610033View on ClinicalTrials.gov

Pilot evaluatIon Of NovEl tEmpoRary ExtraVascular PACING (PIONEER EV PACING) Study

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 19, 2023

Primary Completion Date

December 15, 2023

Study Completion Date

January 12, 2024

Conditions
Conduction Defect
Interventions
DEVICE

AtaCor StealthTrac Lead

Subjects will receive the AtaCor StealthTrac Lead being evaluated in the study.

Trial Locations (1)

21000

University Hospital Center Split, Split

Sponsors
All Listed Sponsors
lead

AtaCor Medical, Inc.

INDUSTRY

NCT05610033 - Pilot evaluatIon Of NovEl tEmpoRary ExtraVascular PACING (PIONEER EV PACING) Study | Biotech Hunter | Biotech Hunter